Anti-synucléine bêta, anticorps C - Terminal produit en lapin,environ 1 mg / mL, anticorps isolé affinité,solution aqueuse tamponnée

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

Synuclein β reduces the effects of synuclein α toxicity in a dose dependent manner by preventing its accumulation. Synuclein β normally, does not form fibrils.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Features and Benefits

Evaluate our antibodies with complete peace of mind. If the antibody does not perform in your application, we will issue a full credit or replacement antibody. Learn more.

General description

Anti-Synuclein β antibody detects endogenous levels of total Synuclein β protein.

The SNCB (synuclein β) gene is mapped to the chromosome 5q35.2. Synuclein β is known to localize along with synuclein α in the presynaptic region of the brain. It contains KTKXGV repeats at its N-terminal, highly acidic and solubilizing region at its C-terminal and a non-amyloid-β component.

Immunogen

The antiserum was produced against synthesized peptide derived from human Synuclein beta.Immunogen Range: 85-134

Physical form

Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.